Módszerek összehasonlítása
Tekintse át a kiválasztott módszereket egymás mellett; az eltérő sorok kiemelve jelennek meg.
| Hill-Bone Compliance Scale (HBCS)× | Kérdőív tablettaszedéshez× | |
|---|---|---|
| Tudományterület | Farmakológia | Farmakológia |
| Módszercsalád | Process / pipeline | Process / pipeline |
| Keletkezés éve≠ | 1999 | 2012 |
| Megalkotó≠ | Marjorie T. Kim, Mozella N. Hill, Lisa R. Bone, and Debra M. Levine | Adeniji and Brown |
| Típus | Self-report | Self-report |
| Alapmű≠ | Kim, M. T., Hill, M. N., Bone, L. R., & Levine, D. M. (1999). Development and Testing of the Hill-Bone Compliance Scale. Journal of Cardiovascular Nursing, 4(1), 54-59. (Also: Hill, M. N., Bone, L. R., & Kim, M. T. (1996). Perspective on compliance research in hypertension. Journal of Clinical Hypertension, 8(1), 12-17.) link ↗ | Adeniji, B., & Brown, C. (2012). Tablet Questionnaire: A simple tool to assess medication non-adherence. Annals of African Medicine, 11(4), 202-205. link ↗ |
| Alternatív nevek≠ | HBCS | Tablet Questionnaire, TAB-Q |
| Kapcsolódó | 4 | 4 |
| Összefoglaló≠ | The Hill-Bone Compliance Scale (HBCS) is a brief, disease-specific self-report measure designed to assess medication and lifestyle adherence in hypertension management. Developed by Kim, Hill, Bone, and Levine at Johns Hopkins University in 1999, the HBCS measures three dimensions of hypertension adherence: medication-taking, dietary sodium restriction, and appointment keeping. Unlike generic adherence measures, the HBCS captures the multifaceted nature of hypertension self-management, recognizing that many hypertensive patients struggle equally with medication adherence and behavioral changes (diet, exercise, weight management, stress management). The scale has demonstrated strong reliability and validity in diverse hypertensive populations and remains widely used in hypertension research and clinical management. | The Tablet Questionnaire is a brief, simple self-report tool designed to assess medication non-adherence through direct questions about dose-skipping behavior and reasons for non-adherence. Developed by Adeniji and Brown in 2012, it prioritizes simplicity and cultural accessibility, making it particularly valuable in low-resource settings and populations with limited health literacy. Despite its brevity, the measure demonstrates good sensitivity for detecting non-adherence and has been validated across African and international populations. |
| ScholarGateAdatkészlet ↗ |
|
|